Provided are caveolin- 1 ligands derived from the anti-HIV therapeutic T20. Substitution of homologous residues into the T20 resulted in the identification of several caveolin- 1 ligands that had higher affinity than wild-type T20. Imaging with the highest affinity caveolin ligand confirmed co-localization of the ligand with endogenous caveolin in NIH 3T3 fibroblast cells.
申请公布号
WO2012122519(A3)
申请公布日期
2012.10.18
申请号
WO2012US28595
申请日期
2012.03.09
申请人
WEISS, GREGORY, A.;MAJUMDAR, SUDIPTA;HAJDUCSKI, AGNES;THOMPSON, TRAVIS, D.;MENDEZ, AARON, S.
发明人
WEISS, GREGORY, A.;MAJUMDAR, SUDIPTA;HAJDUCSKI, AGNES;THOMPSON, TRAVIS, D.;MENDEZ, AARON, S.